2023
DOI: 10.1016/j.yrtph.2023.105388
|View full text |Cite
|
Sign up to set email alerts
|

Artificial intelligence and real-world data for drug and food safety – A regulatory science perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…We then assessed RxBERT on two common NLP tasks: NER and Text Classification, both of which have already been widely applied in the regulatory research of drug labeling. [20][21][22] RxBERT showed competitive results compared to previous approaches in both tasks. In particular, for the drug labeling sentence classification task, RxBERT outperforms a collection of BERT-based models, including the biomedical domain-specific model BioBERT, which was pretrained on PubMed abstracts and used to initialize RxBERT.…”
Section: Discussionmentioning
confidence: 89%
“…We then assessed RxBERT on two common NLP tasks: NER and Text Classification, both of which have already been widely applied in the regulatory research of drug labeling. [20][21][22] RxBERT showed competitive results compared to previous approaches in both tasks. In particular, for the drug labeling sentence classification task, RxBERT outperforms a collection of BERT-based models, including the biomedical domain-specific model BioBERT, which was pretrained on PubMed abstracts and used to initialize RxBERT.…”
Section: Discussionmentioning
confidence: 89%
“…Real‐world data have already found uses in daily practice, whereas AI could help agencies to improve their operation. Data standardization will be key in this regard (Thakkar et al., 2023).…”
Section: Recommendationsmentioning
confidence: 99%
“…Moreover, collaboration can facilitate communication and knowledge sharing among stakeholders, leading to improved decision-making and more effective risk assessments. Collaboration can also enhance transparency and accountability in the development and implementation of digital technologies, ensuring that the interests of all stakeholders are taken into account …”
Section: Challenges and Limitations Associated With Implementing Digi...mentioning
confidence: 99%
“…Collaboration can also enhance transparency and accountability in the development and implementation of digital technologies, ensuring that the interests of all stakeholders are taken into account. 83 The implementation of digital technologies in toxicology requires essential collaboration among interdisciplinary researchers and stakeholders since there are technical barriers such as the complexity of integrating different systems and platforms. Digital technologies rely on a range of hardware and software solutions, and compatibility issues can arise when integrating these technologies with existing systems.…”
Section: With Implementing Digital Technologies In Toxicologymentioning
confidence: 99%